Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Failure of stavudine-lamivudine combination therapy in antiretroviral-naive patients with AZT-like HIV-1 resistance mutations.

Journal of medical virology - 1 Dec 2001

Sarmati L, Nicastri E, Parisi S G, D'Ettorre G, Narciso P, Mancino G, Gallo I, Abbadessa V, Dalle N E, Traina C, Vullo V, Andreoni M

Abstract excerpt

To analyze the clinical relevance of AZT resistance mutations in AZT-naive patients, 56 HIV-1 seropositive patients treated for 18 months with stavudine/lamivudine (27 patients) or AZT/lamivudine (29 patients) were studied. AZT-like resistance mutations were found in 13 out of 29 (44%) patients treated with AZT/lamivudine and in 11 out of 27 (40%) patients treated with stavudine/lamivudine. No stavudine or...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Anti-HIV Agents
Share to Drug Resistance, Viral

Methodology Data sources Editorial policy Privacy Delete account & data About Contact Helena Bioinformatics

Share to Drug Therapy, Combination

Share to HIV Seropositivity

Share to Lamivudine

Share to Stavudine

Share to Treatment Failure

Share to Zidovudine

Source

Identifiers

PMID: 11745924
DOI: 10.1002/jmv.2083

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-08.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence. Graph snapshot: 2026-09-29.

Research trail→

Click a neighbor to travelStep 1 · 9 closest

Failure of stavudine-lamivudine combination therapy in antiretroviral-naive patients with AZT-like HIV-1 resistance mutations.PMID 11745924Read ↗

Potential Mechanism for Sustained Antiretroviral Efficacy of AZT-3TC Combination TherapySemantic proximity Read ↗

Long-term persistence of AZT-resistance mutations in the plasma HIV-1 of patients removed from AZT therapy.Semantic proximity Read ↗

Loss of zidovudine related mutations in the reverse transscriptase gene of HIV after switching therapy.Semantic proximity Read ↗

Resistance to ddI and sensitivity to AZT induced by a mutation in HIV-1 reverse transcriptase.Semantic proximity Read ↗

Predominance of codon 215 mutation in reverse transcriptase-coding region of 3'-azido-3'-deoxythymidine (AZT)-resistant HIV-1 isolates after long-term AZT therapy.Semantic proximity Read ↗

Long-term persistence of zidovudine resistance mutations in plasma isolates of human immunodeficiency virus type 1 of dideoxyinosine-treated patients removed from zidovudine therapy.Semantic proximity Read ↗

Mutations in the HIV type 1 integrase of patients receiving long-term dideoxynucleoside therapy do not confer resistance to zidovudine.Semantic proximity Read ↗

[Reverse transcriptase gene analysis of HIV-1 mutants cultured in the presence of AZT].Semantic proximity Read ↗

[Stability of human immunodeficiency virus to azidothymidine. II. Kinetic characteristics of "AZT-resistant" mutant forms of reverse transcriptase].Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.